ATE484195T1 - Gewebe-engineering - Google Patents

Gewebe-engineering

Info

Publication number
ATE484195T1
ATE484195T1 AT03728251T AT03728251T ATE484195T1 AT E484195 T1 ATE484195 T1 AT E484195T1 AT 03728251 T AT03728251 T AT 03728251T AT 03728251 T AT03728251 T AT 03728251T AT E484195 T1 ATE484195 T1 AT E484195T1
Authority
AT
Austria
Prior art keywords
tissue engineering
engineering
lifespan
extending
general
Prior art date
Application number
AT03728251T
Other languages
English (en)
Inventor
Laura Niklason
J Mckee
Christopher Counter
Original Assignee
Univ Duke
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Duke filed Critical Univ Duke
Application granted granted Critical
Publication of ATE484195T1 publication Critical patent/ATE484195T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/12—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
    • C12N9/1241—Nucleotidyltransferases (2.7.7)
    • C12N9/1276—RNA-directed DNA polymerase (2.7.7.49), i.e. reverse transcriptase or telomerase
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/069—Vascular Endothelial cells
    • C12N5/0691—Vascular smooth muscle cells; 3D culture thereof, e.g. models of blood vessels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/30—Organic components
    • C12N2500/32—Amino acids
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2510/00—Genetically modified cells
    • C12N2510/04—Immortalised cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2533/00—Supports or coatings for cell culture, characterised by material
    • C12N2533/30—Synthetic polymers
    • C12N2533/40—Polyhydroxyacids, e.g. polymers of glycolic or lactic acid (PGA, PLA, PLGA); Bioresorbable polymers

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Vascular Medicine (AREA)
  • Cell Biology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Diaphragms For Electromechanical Transducers (AREA)
  • Saccharide Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT03728251T 2002-03-15 2003-03-17 Gewebe-engineering ATE484195T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US36408702P 2002-03-15 2002-03-15
PCT/US2003/008054 WO2003078597A2 (en) 2002-03-15 2003-03-17 Tissue engineering

Publications (1)

Publication Number Publication Date
ATE484195T1 true ATE484195T1 (de) 2010-10-15

Family

ID=28041870

Family Applications (1)

Application Number Title Priority Date Filing Date
AT03728251T ATE484195T1 (de) 2002-03-15 2003-03-17 Gewebe-engineering

Country Status (8)

Country Link
US (1) US7943378B2 (de)
EP (1) EP1487274B1 (de)
AT (1) ATE484195T1 (de)
AU (1) AU2003233404A1 (de)
CA (1) CA2479512C (de)
DE (1) DE60334533D1 (de)
ES (1) ES2353665T3 (de)
WO (1) WO2003078597A2 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2419817C (en) * 2000-08-16 2014-11-18 Duke University Decellularized tissue engineered constructs and tissues
US20060052324A1 (en) * 2004-08-05 2006-03-09 Artandi Steven E Methods and compositions for cell activation
EP1693025A1 (de) 2005-02-17 2006-08-23 Universität Zürich Verfahren zur Herstellung einer Prothese aus Gewebe
US20130013083A1 (en) * 2011-01-06 2013-01-10 Humacyte Tissue-Engineered Constructs
EP2661243B1 (de) 2011-01-06 2022-10-12 Humacyte, Inc. Gewebegezüchtete konstrukte

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6172210B1 (en) * 1996-04-02 2001-01-09 Blood Center Research Foundation DNA encoding phospholipid scramblase
US6331406B1 (en) * 1997-03-31 2001-12-18 The John Hopkins University School Of Medicine Human enbryonic germ cell and methods of use
EP0893493A3 (de) 1997-07-21 2002-12-04 Aventis Pharma Deutschland GmbH Genetisch veränderte Zellen und deren Verwendung in der Prophylaxe oder Therapie von Erkrankungen
WO1999035245A2 (en) * 1998-01-12 1999-07-15 Board Of Regents, The University Of Texas System Methods for preparing and using immortalized human neuroendocrine cells
US6399384B1 (en) * 1999-09-17 2002-06-04 Reneuron Limited Conditional immortalization of cells
JP2004529614A (ja) * 2000-11-20 2004-09-30 カリフォルニア・インスティテュート・オブ・テクノロジー 動脈平滑筋及び静脈平滑筋並びにそれらの利用
US20040044403A1 (en) * 2001-10-30 2004-03-04 Joyce Bischoff Tissue-engineered vascular structures
EP1451299A4 (de) * 2001-12-11 2008-03-05 Cytograft Tissue Engineering I Durch tissue-engineering gebildete zellagen, verfahren zur herstellung und verwendung davon
US20030175961A1 (en) * 2002-02-26 2003-09-18 Herron G. Scott Immortal micorvascular endothelial cells and uses thereof

Also Published As

Publication number Publication date
WO2003078597A2 (en) 2003-09-25
WO2003078597A9 (en) 2003-12-11
WO2003078597A3 (en) 2004-04-08
DE60334533D1 (de) 2010-11-25
EP1487274B1 (de) 2010-10-13
EP1487274A4 (de) 2006-06-21
US20030235562A1 (en) 2003-12-25
CA2479512A1 (en) 2003-09-25
AU2003233404A8 (en) 2003-09-29
CA2479512C (en) 2012-10-16
EP1487274A2 (de) 2004-12-22
US7943378B2 (en) 2011-05-17
ES2353665T3 (es) 2011-03-03
AU2003233404A1 (en) 2003-09-29

Similar Documents

Publication Publication Date Title
ATE427763T1 (de) Ballonkatheter
NO20062649L (no) Biarylsulfonamider og metoder for anvendelse av disse
BRPI0312331A2 (pt) composições de ácido hialurônico e métodos de emprego.
IS7764A (is) Glútamín-þíasólidíð og -pýrrólidíð og notkun þeirra sem dípeptidýlpeptíðasa IV hindrar
ATE489101T1 (de) Wiederherstellung der gelenken mit mesenchymalen stammzellen
BRPI0409367A (pt) derivados de piperidina inibidores de renina
ZA200501677B (en) Hydantoin derivatives and their use as TACE inhibitors.
ATE526991T1 (de) Zusammensetzungen und ihre verwendungen für die gentherapeutische behandlung von knochenerkrankungen
UY27143A1 (es) Inhibidores de sulfonamida lactama de fxa y método
EA200900344A1 (ru) Циклические ингибиторы 11-бета-гидроксистероиддегидрогеназы типа i
PL375900A1 (en) Dosage forms containing a proton pump inhibitor, a nsaid, and a buffer
TW200519089A (en) Biaryl sulfonamides and methods for using same
WO2007028079A3 (en) Methods of stimulating expansion of hematopoietic stem cells
CY1108599T1 (el) Η απλιδινη στην αντιμετωπιση του πολλαπλου μυελωματος
MX2007002277A (es) Metodos para formar retinoides y usos de los mismos.
DK1773420T3 (da) Anvendelse af gingivale fibroblaster til vaskulær celleterapi
MX2007002917A (es) Todo-trans-retinol: todo-trans-13, 14-dihidrorretinol saturasa y metodos de uso de la misma.
ATE549024T1 (de) Chinazolin-kaliumkanalhemmer
ECSP045466A (es) Inhibidores de la peptido-desformilasa
TW200508233A (en) Chk-1 inhibitors
RS51534B (en) NEW COMPOUND OF SINUSOID IF CURRENT INHIBITORS AND CALCIUM INHIBITOR AND PHARMACEUTICAL MIXTURE CONTAINED BY IT
DE60334533D1 (de) Gewebe-engineering
ITRM20020115A0 (it) Espressione di enzimi lisosomiali in seme.
ATE533779T1 (de) Isoliertes photoprotein mtclytin, sowie dessen verwendung
DE50305974D1 (de) Rollstuhl, insbesondere Elektrorollstuhl

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties